Advances in Lymphoma: Report from ASCO and EHA 2025
Podcast Episode · Healthcare Unfiltered · 07/22/2025 · 44m
Related Articles
Eprenetapopt and Azacitidine Effective for TP53-Mutated MDS/AML SOHO Insider
Phase 2 study shows eprenetapopt and azacitidine achieve 69% response rate in TP53-mutated MDS/AML, with 41% complete remission.
Partnering in Care: Chronic Lymphocytic Leukemia (CLL) – The Bloodline with LLS
In this episode, we’re joined by Dr. Marc Hoffmann from The University of Kansas Cancer Center, to explore chronic lymphocytic leukemia (CLL)—what it is, how…
Scheduled: “Thoughts on Blenrep” LIVE taping of Healthcare Unfiltered – EXPRESS
chadi nabhan MD, MBA, FACP’s Space · Where live audio conversations happen
Advancing Cardiac Arrest Care, SPEAR; Roadside to Resus
Podcast Episode · The Resus Room · 22/07/2025 · 1h 10m
Podcast Episode: Structural Heart Disease, Obesity-Related Heart Failure, Private Equity Ownership in Hospitals | JACC This Week
In this episode of JACC This Week, Editor-in-Chief Dr. Harlan Krumholz introduces the journal’s new design and highlights key studies from the July 29, 2025…
Scheduled: “Thoughts on Blenrep” LIVE taping of Healthcare Unfiltered – EXPRESS
chadi nabhan MD, MBA, FACP’s Space · Where live audio conversations happen
Cardiovascular Concerns, Cancer Treatment, and Biological and Chronological Aging in Cancer: JACC Family Series
AbstractCardiovascular disease (CVD) and cancer are leading causes of death globally, particularly among the rapidly growing population of older adults (OAs). CVD is a leading…
Boosting gut-friendly foods may slow biological aging, large US study finds
Higher scores on a dietary index linked to gut microbiota health are associated with slower biological aging in US adults, according to a large cross-sectional…
Alzheimer’s risk could rise with specific sleep pattern, experts warn
A new study has found a link between rapid eye movement (REM) sleep and Alzheimer’s disease.